Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats
Horsley, R. R., Páleníček, T., Kolin, J., & Valeš, K. | Behavioural pharmacology | 13 March 2018
MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
Feduccia, A. A., & Mithoefer, M. C. | Progress in neuro-psychopharmacology and biological psychiatry | 7 March 2018
The re-emergence of hallucinogenic research
Begola, M. J., & Dowben, J. S. | Perspectives in psychiatric care | 20 February 2018
The re-emergence of hallucinogenic research
Begola, M. J., & Dowben, J. S. | Perspectives in psychiatric care | 20 February 2018
Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulation
Curran, H. V., Nutt, D., & de Wit, H. | Psychopharmacology | 14 February 2018
Taking Psychedelics Seriously
Byock, I. | Journal of palliative medicine | 22 January 2018
Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder
Thal, S. B., & Lommen, M. J. | Journal of Contemporary Psychotherapy | 6 January 2018
Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression
Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. | Frontiers in Pharmacology | 20 December 2017
Progress and promise for the MDMA drug development program
Feduccia, A. A., Holland, J., & Mithoefer, M. C. | Psychopharmacology | 20 November 2017
Dying to live: The power of transcendence in the treatment of existential anxiety
Gandy, S. | Threshold: Journal of Interdisciplinary Consciousness Studies | 2 November 2017
Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice
Curry, D. W., Young, M. B., Tran, A. N., Daoud, G. E., & Howell, L. L. | Neuropharmacology | 6 October 2017
A retrospective study of ketamine administration and the development of acute or post-traumatic stress disorder in 274 war-wounded soldiers
Mion, G., Le Masson, J., Granier, C., & Hoffmann, C. | Anaesthesia | 3 October 2017
Psychedelic Drugs in Biomedicine
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. | Trends in Pharmacological Sciences | 22 September 2017
Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review
Reiche, S., Hermle, L., Gutwinski, S., Jungaberle, H., Gasser, P., & Majić, T. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 22 September 2017
Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic
Krystal, J. H., Abdallah, C. G., Averill, L. A., Kelmendi, B., Harpaz-Rotem, I., Sanacora, G., ... & Duman, R. S. | Current Psychiatry Reports | 26 August 2017
Trauma Interventions using Mindfulness Based Extinction and Reconsolidation (TIMBER) psychotherapy prolong the therapeutic effects of single ketamine infusion on post-traumatic stress disorder and comorbid depression: a pilot randomized, placebo-controlled, crossover clinical trial
Pradhan, B. K., Wainer, I. W., Moaddel, R., Torjman, M. C., Goldberg, M., Sabia, M., ... & Pumariega, A. J. | Asia Pacific Journal of Clinical Trials: Nervous System Diseases | 2 August 2017
Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges
Majić, T., Jungaberle, H., Schmidt, T. T., Zeuch, A., Hermle, L., & Gallinat, J. | Fortschritte der Neurologie-Psychiatrie | 2 August 2017
Behavioral Changes Over Time Following Ayahuasca Exposure in Zebrafish
Savoldi, R., Polari, D., Pinheiro-da-Silva, J., Silva, P. F., Lobao-Soares, B., Yonamine, M., ... & Luchiari, A. C. | Frontiers in behavioral neuroscience | 28 July 2017
The 2017 Ayahuasca Technical Report
ICEERS has just released the 2017 edition of the Ayahuasca Technical Report. Signed by ten of the world’s leading ayahuasca researchers, this report is an important document that summarizes the most relevant scientific findings from [...]
Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA)
Young, M. B., Norrholm, S. D., Khoury, L. M., Jovanovic, T., Rauch, S. A., Reiff, C. M., ... & Howell, L. L. | Psychopharmacology | 24 July 2017
Posttraumatic Stress Disorder: An Integrated Overview of the Neurobiological Rationale for Pharmacology
Kelmendi, B., Adams, T. G., Southwick, S., Abdallah, C. G., & Krystal, J. H. | Clinical Psychology: Science and Practice | 18 July 2017
Ayahuasca: what mental health professionals need to know
Santos, R. G. D., Bouso, J. C., & Hallak, J. E. C. | Archives of Clinical Psychiatry (São Paulo) | 1 July 2017
Psilocybin-assisted therapy for anxiety and depression: implications for euthanasia
Strauss, N. | The Medical Journal of Australia | 19 June 2017
Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress
Swift, T. C., Belser, A. B., Agin-Liebes, G., Devenot, N., Terrana, S., Friedman, H. L., ... & Ross, S. | Journal of Humanistic Psychology | 14 June 2017
Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy
Wagner, M. T., Mithoefer, M. C., Mithoefer, A. T., MacAulay, R. K., Jerome, L., Yazar-Klosinski, B., & Doblin, R. | Journal of Psychopharmacology | 1 June 2017